Development of a rapid cow-side bacteriophage-based diagnostic method for the detection of Staphylococcus aureus mastitis

Lead Research Organisation: University of Warwick
Department Name: School of Life Sciences

Abstract

Bovine mastitis is an inflammatory condition of the udder, typically caused by bacterial infections in dairy cattle. One of the hardest bacterial pathogens to tackle, responsible for bovine mastitis, is Staphylococcus aureus. This condition has severe economic and societal implications. Economic due to both indirect and direct costs that arise from factors including increased veterinary and labour costs and reduced milk yield and quality. Societal, due to the strains placed on public health, with the overuse of antibiotics in farms, which results to increase in the problem of antimicrobial resistance with negative effects in human health and agriculture. The current methods of diagnosis and treatment require improvement, as these are not always straightforward. In terms of the treatment and because many times the bacterial strain responsible for the infection is hard to be determined, strong broad-spectrum antibiotics are used, which in the long run increase the serious problem of antimicrobial resistance, that is the resistance of bacterial pathogens to antibiotics, posing threats on the public health.

It is therefore an urgent need to develop a rapid cow-side test for Bovine mastitis, which would provide a fundamental change in the control and treatment of S. aureus mastitis. We will focus on the detection of infection caused by Staphylococcus aureus.

For this purpose, we will use bacteriophages, specific for targeting Staphylococcus aureus, as the basis of the diagnostic method. Bacteriophages are viruses with great specificity to their bacterial host. We will genetically modify these bacteriophages to be made bioluminescent, so that in the presence of Staphylococcus aureus in the samples tested, luminescence will be produced. We will further spray dry these phages to convert those into a powder, which can be easily distributed to individual vials and form the basis of the diagnostic test. The bioluminescent bacteriophages will be optimised and will be further be tested in the field, using biological samples from cows, both in their liquid and powder format, in order to ensure their accuracy and sensitivity. Overall, we aim to develop a rapid cow-side bacteriophage-based diagnostic method for Staphylococcus aureus bovine mastitis.

Technical Summary

A proposed solution to the rapid diagnosis of Staphylococcus aureus bovine mastitis, is the use of genetically modified bacteriophages as diagnostics. In this proposal, we will genetically modify phage K, a phage that specifically targets Staphylococcus aureus. We will design a construct with flanking regions to non-essential areas of the genome of the phage, containing a luxAB cassette, so that a stable bioluminescent K phage can be engineered.
This construct will be transformed into Staphylococcus aureus electrocompetent cells and a recombinant phage will be constructed via homologous recombination. The recombinant bioluminescent phages will be selected by plaque PCR using primers that flank the luxAB cassette, following plaque assay and a plaque that contains the correct recombinant phage will be further processed, purified and assessed for stability. In vitro experiments, combining Staph. aureus growth and then incubation with the phage, measured in different time points with luminometer, will reveal the ability of the bioluminescent phage to transduce bioluminescence and will enable us to find the optimal conditions. The bioluminescent phage will be further spray dried to be converted into powder formulation and will be distributed in vials for easy use. The liquid bioluminescent phage and the one in powder format will be tested for diagnostic accuracy and sensitivity in real conditions, using initially a selection of isolates from the large collection of bacteria that have been isolated at Cambridge. Further, these will be tested in stored mastitis samples with known microbiological diagnoses. Finally, these will be used as diagnostics directly to the dairy herd at the University Farm in Cambridge using conventional microbiology. The above will provide sensitivity and specificity values for the diagnostic method in field conditions and will form the basis for a rapid cow-side bacteriophage based diagnostic test for Staphylococcus aureus mastitis.

Publications

10 25 50
 
Description We have now completed the experimental results of this project. We have managed to construct a bioluminescent K phage, that targets staph aureus and we have seen now that in the presence of the bacterial pathogen, it gives higher signal of bioluminescence, when measured via a luminometer.

We have optimised the conditions and we are now waiting from Loughborough to make this phage into a powder format and then test this further. Our original recombinant phage is already tested towards clinical veterinary cow mastitis samples, as well as controls of other pathogens-sent to us from Cambridge, so we have all the data needed. Next, we need to wrap these up, submit papers and grants to ask for further funding.
Exploitation Route papers and grants
Sectors Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

 
Title A bioluminescent staphylococcus aureus phage has been engineered 
Description we have engineered already a luxAB staph K phage to be used for the detection of cow mastitis caused by staphylococcus aureus. 
Type Of Material Technology assay or reagent 
Year Produced 2021 
Provided To Others? No  
Impact we aim to use this further upon optimisation for detection of infection as a diagnostic tool 
 
Title Infection of Staphylococcus aureus samples with staph bioluminescent phage. 
Description The collaborators in Cambridge carried out some initial testing work in the lab, trying to infect different STs of S. aureus with phage K in both liquid culture and on agar plates. The results require further optimization, but look promising in the specificity of the phage towards the s.aureus samples. 
Type Of Material Biological samples 
Year Produced 2022 
Provided To Others? No  
Impact We will be able upon optimization to establish K bioluminescent phage as a diagnostic of infection. 
 
Description Collaboration with Professor Mark Holmes, University of Cambridge. 
Organisation University of Cambridge
Department Veterinary School
Country United Kingdom 
Sector Academic/University 
PI Contribution Together with Professor Holmes, we are working on this project. He will provide the expertise in animals and I am providing the expertise in phages.
Collaborator Contribution animal samples-expertise in animals from Cambridge, expertise in phages from Warwick.
Impact we had some meetings already, we have sent over to Cambridge the bioluminescent phages and we are both working on the project.
Start Year 2021
 
Description collaboration with Dr Danish Malik 
Organisation Loughborough University
Country United Kingdom 
Sector Academic/University 
PI Contribution we have sent the K bioluminescent phage over to Loughborough, this was constructed by my lab.
Collaborator Contribution we expect Dr Malik's lab to encapsulate this phage and also made this into powder format.
Impact we need to complete what was described above to move further with the project and we will submit further funding ti expand the application of the staph phage further to target veterinary staph infections.
Start Year 2021
 
Description Expert opinion on AMR 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact I was approached by University of Warwick initially and then media, to provide my expert opinion and an interview to the problem of AMR.
Year(s) Of Engagement Activity 2022
URL https://www.voanews.com/a/superbugs-deadlier-than-aids-malaria-study-shows/6405622.html
 
Description expert opinion on AMR 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Undergraduate students
Results and Impact As mentioned, I provided expert opinion through Warwick and then was asked to comment on media internationally.
Year(s) Of Engagement Activity 2022
URL https://warwick.ac.uk/newsandevents/expertcomment/antibiotic-resistant_infections_we
 
Description new interviews to media 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact I was interviewed in the media (Daily ?ail, Voice of America, Royal society of biology, Microbiology society, New Statesman), by BBSRC Impact Showcase, which introduces some of the people BBSRC are investing in and who in turn work with BBSRC to support world-class bioscience for everyone BBSRC Impact Showcase 2022 and by BBSRC senior managers on AMR: Report Publication Page: Evaluating BBSRC investments in antimicrobial resistance research - UKRI, Blog post: : Informing BBSRC's future AMR research strategy - UKRI.
Year(s) Of Engagement Activity 2022
URL https://www.ukri.org/blog/informing-bbsrcs-future-amr-research-strategy/